Insider Shareholders with Direct Ownership of Avalo Therapeutics, Inc. (AVTX)
This section provides a comprehensive overview of the insiders with direct ownership of Avalo Therapeutics, Inc. (AVTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Avalo Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Armistice Capital, Llc
> 10% Shareholder |
26,969,671 | 3,455,129 | 39,100,000 $331 Million | 129 |
May 18, 2021
Added 0.06%
|
|
Garry Arthur Neil
Chief Executive Officer |
82,508 | 17,787 | 47,140 $398,804 | 7 |
Mar 28, 2025
Reduced 27.4%
|
|
James Archie Harrell Jr
Chief Commercial Officer |
8,757 | 0 | 36,766 $311,040 | 3 |
Dec 10, 2021
Added 2.89%
|
|
H Jeffrey Wilkins
Chief Medical Officer |
7,283 | 0 | 33,373 $282,335 | 2 |
Dec 10, 2021
Added 16.03%
|
|
Christopher Ryan Sullivan
Chief Financial Officer |
30,761 | 7,285 | 16,921 $143,151 | 5 |
Mar 28, 2025
Reduced 30.1%
|
| 2,883 | 0 | 3,883 $32,850 | 2 |
Dec 10, 2021
Added 36.49%
|
|
|
Gilla Kaplan
Director |
3,167 | 0 | 3,167 $26,792 | 1 |
Mar 28, 2025
Added 50.0%
|
|
Mitchell Chan
Director |
3,167 | 0 | 3,167 $26,792 | 1 |
Mar 28, 2025
Added 50.0%
|
|
June Sherie Almenoff
Director |
3,167 | 0 | 3,167 $26,792 | 1 |
Mar 28, 2025
Added 50.0%
|
|
Aaron Kantoff
Director |
3,167 | 0 | 3,167 $26,792 | 1 |
Mar 28, 2025
Added 50.0%
|
|
Samantha Truex
Director |
3,167 | 0 | 3,167 $26,792 | 1 |
Mar 28, 2025
Added 50.0%
|
|
Jonathan Goldman
Director |
3,167 | 0 | 3,167 $26,792 | 1 |
Mar 28, 2025
Added 50.0%
|
|
Caissa Capital Management Ltd.
> 10% Shareholder |
0 | 182,300 | 0 $0 | 1 |
Jun 26, 2023
Reduced 100.0%
|